Spire Wealth Management - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,531
+30.5%
616
+23.2%
0.00%0.0%
Q2 2023$18,035
-5.6%
5000.0%0.00%0.0%
Q1 2023$19,095
+63550.0%
500
-4.4%
0.00%
-50.0%
Q4 2022$30
-99.9%
523
-9.7%
0.00%
+100.0%
Q3 2022$23,000
-99.7%
579
-99.6%
0.00%
-99.7%
Q2 2022$7,180,000
+8764.2%
163,186
+8006.6%
0.30%
+14700.0%
Q4 2021$81,000
+3950.0%
2,013
+3200.0%
0.00%
Q3 2021$2,000
-97.6%
61
-97.0%
0.00%
-100.0%
Q1 2021$83,0002,0130.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders